Compare SQNS & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQNS | CCEL |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | France | United States |
| Employees | N/A | 76 |
| Industry | Semiconductors | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0M | 41.8M |
| IPO Year | 2011 | 2022 |
| Metric | SQNS | CCEL |
|---|---|---|
| Price | $2.54 | $5.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | ★ 57.0K | 11.9K |
| Earning Date | 11-03-2026 | 10-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | $34.42 | N/A |
| Revenue Next Year | $60.58 | N/A |
| P/E Ratio | ★ N/A | $22.22 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $2.31 | $2.72 |
| 52 Week High | $6.98 | $5.45 |
| Indicator | SQNS | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 62.09 |
| Support Level | $2.37 | $3.16 |
| Resistance Level | $3.19 | N/A |
| Average True Range (ATR) | 0.15 | 0.41 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 38.78 | 81.34 |
Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.